GlassScriptPhysician profile
Kheder Kutmah
NPI 1487666228
$1,521.36
in general payments reported to CMS, 2019-2025
20 companies · $255 in 2025
The $255 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $186 · 2020: $212 · 2021: $172 · 2022: $272 · 2023: $123 · 2024: $303 · 2025: $255.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $580 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $579.88 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $278.68 | 2021-2024 | Ofev |
| Harmony Biosciences LLC | $200.24 | 2022-2025 | |
| Sunovion Pharmaceuticals INC. | $143.97 | 2020-2021 | |
| Philips North America LLC | $135.46 | 2019-2024 | (Af1) Full Face Masks - Traditional |
| Genzyme Corporation | $134.55 | 2024-2025 | |
| Regeneron Healthcare Solutions, INC. | $116.04 | 2024-2025 | Dupixent |
| Astrazeneca Pharmaceuticals LP | $109.11 | 2019-2021 | |
| Teleflex LLC | $105.65 | 2023 | Turnpike |
| Mylan Specialty L.P. | $82.63 | 2019-2024 | Yupelri |
| Glaxosmithkline, LLC. | $38.88 | 2020-2022 | |
| Nabriva Therapeutics, Plc | $28.87 | 2020 | |
| Mallinckrodt Hospital Products INC. | $22.24 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $21.78 | 2024 | Glassia |
| Verona Pharma, INC. | $17.54 | 2025 | Ohtuvayre |
| Axsome Therapeutics, INC. | $16.93 | 2023 | Sunosi |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $16.49 | 2024 | Tavneos |
| Inogen, INC. | $14.80 | 2022 | |
| Ge Healthcare | $12.85 | 2020 | |
| Avanir Pharmaceuticals, INC. | $12.45 | 2020 | |
| Jazz Pharmaceuticals INC. | $12.20 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kheder Kutmah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.